Sudarshan Pharma Industries Ltd IPO

BSE SME

Listed On: Mar 22, 2023 at ₹ 73.0

₹ 116800 /1600 Shares

Check Allotment

Sudarshan Pharma Industries Ltd IPO Details

09 Mar, 2023

Open Date

14 Mar, 2023

Close Date

17 Mar, 2023

Allotment Date

22 Mar, 2023

Listing Date

Issue Price

₹71-73 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

BSE SME

Registrar

KFin Technologies Limited

List Price

73.0

Listing Date

2023-03-22

Market Lot

1600 Shares (₹116,800/-)

Lead Manager

Gretex Corporate Services Pvt Ltd

Issue Size

Fresh Issue : 6,862,400 shares of ₹10(aggregating up to ₹50.10 Cr)

Retail Portion

N/A

Subscription

1.06 times

IPO Docs

DRHP RHP

Sudarshan Pharma Industries Ltd IPO Subscription Details

As on	QIB / NII	Retail	Total
Shares Offered / Reserved	521,600 / 1,908,800	3,651,200	6,081,600
Day 1 - 09-03-23 06:00 PM	0.00 / 0.37 x	0.46 x	0.40 x
Day 2 - 10-03-23 06:00 PM	0.00 / 0.38 x	0.67 x	0.52 x
Day 3 - 13-03-23 06:00 PM	0.00 / 0.58 x	0.88 x	0.71 x
Day 4 - 14-03-23 06:00 PM	1.01 / 0.81 x	1.20 x	1.06 x

Sudarshan Pharma Industries Ltd Valuations

Earnings Per Share (EPS)

₹3.39/-

P/E Ratio

N/A

RoNW

17.63%

Net Asset Value (NAV) - Post Issue

₹30.54/-

Sudarshan Pharma Industries Ltd Company Financials All values are in ₹ Lakh

	30-Jun-22	31-Mar-22	31-Mar-21	31-Mar-20
Assets	14,703.74	13,752.18	9,926.02	N/A
Revenue	10,587.79	35,755.89	19,372.82	N/A
Profit After Tax	225.37	530.37	267.12	N/A

About The Company

Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.

The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.

The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.

Sudarshan Pharma Industries Ltd - Promoter(s)

Pre Issue Share Holding: 80.28%

Post Issue Share Holding: %

Company Promoter(s)

Mr. Hemal Vasantrai Mehta
Mr. Sachin Vasantrai Mehta

Sudarshan Pharma Industries Ltd IPO - Issue Objectives

Working Capital Requirements
General Corporate Purposes.

Sudarshan Pharma Industries Ltd IPO - FAQs

Ans. Sudarshan Pharma Industries Ltd IPO is a SME IPO. The issue is priced at ₹71-73 per equity share. The minimum order quantity is 1600 Shares. The IPO opens on Mar 9, 2023, and closes on Mar 14, 2023. KFin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

Ans. The Sudarshan Pharma Industries Ltd IPO opens on Mar 9, 2023 and closes on Mar 14, 2023.

Ans. The size of Sudarshan Pharma Industries Ltd IPO is Fresh Issue : 6,862,400 shares of ₹10(aggregating up to ₹50.10 Cr).

Ans. The IPO price band is set between ₹71-73 per equity share.

Ans. To apply for Sudarshan Pharma Industries Ltd IPO IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Sudarshan Pharma Industries Ltd IPO in the List of IPOs
- Press "Apply" Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Sudarshan Pharma Industries Ltd IPO is Mar 17, 2023.

Ans. The Sudarshan Pharma Industries Ltd IPO will be listed on Mar 22, 2023.

Ans. Follow the steps to check the allotment status for Sudarshan Pharma Industries Ltd IPO here.